ID
26088
Description
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00617942
Link
https://clinicaltrials.gov/show/NCT00617942
Keywords
Versions (1)
- 10/9/17 10/9/17 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
October 9, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00617942
Eligibility Breast Cancer NCT00617942
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00617942
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C3714786 (UMLS CUI [3])
C3258246 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2])
C0032961 (UMLS CUI [3])
C0006147 (UMLS CUI [4])
C1515119 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C1514873 (UMLS CUI [1,2])
C1514471 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C1512413 (UMLS CUI [3,1])
C1514873 (UMLS CUI [3,2])
C0521317 (UMLS CUI [1,2])
C0428772 (UMLS CUI [2,1])
C0013516 (UMLS CUI [2,2])
C1516728 (UMLS CUI [1,2])
C0021044 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C1977461 (UMLS CUI [3])